Bixiye
QP5-20 Pharmacy Benefit Exclusions
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Natiijooyinka Raadinta
Soo bandhiga 2101 - 2110 ee natiijooyinka 4296
Bixiye
QP3-20 Addition of Mille Lacs Corporate Ventures to the American Indian Tribal Fee Schedule for Eligible Facility and Professional Services Provided to Purchased/Referred Care (PRC) – Eligible American Indians
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP2-20 MHCP Medical Dental Claim Denials
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2020
Bixiye
QP40R1-19 Medical Drug Update for Drug Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP40-19 Medical Drug Update for New to Market Golodirsen (Vyondys 53)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
P1-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective March 2, 2020
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
P8-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
2020 January Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
P6-20 Sleep Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020
Bixiye
P3-20 Radiology Oncology Imaging Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2020